BCP	β-caryophyllene
CB2	Cannabinoid receptor type 2
TRP	Transient receptor potential
NF-κB	Nuclear Factor kappa-light-chain-enhancer of activated B cells
COX-2	Cyclooxygenase-2
IL-1β	Interleukin 1 beta
TNF-α	Tumour Necrosis Factor alpha
ACC	Anterior cingulate cortex
BNST	Bed nucleus of the stria terminalis
NSAIDs	Nonsteroidal anti-inflammatory drugs
Nav	Voltage-gated sodium channel
Cav	Voltage-gated calcium channel
Kv	Voltage-gated potassium channel
TRPV1	Transient receptor potential vanilloid 1
THC	Δ9-Tetrahydrocannabinol
CBD	Cannabidiol
CB1	Cannabinoid receptor type 1
RCTs	Randomized controlled trials
MAPK	Mitogen-activated protein kinase
PKC	Protein Kinase C
TRPA1	Transient Receptor Potential Ankyrin 1
GABAA	Gamma-Aminobutyric Acid Type A receptor
IκBα	Inhibitor of kappa B alpha
IL-6	Interleukin-6
CD11b	Cluster of differentiation molecule 11B
Iba-1	Ionized calcium-binding adapter molecule 1
MAGL	Monoacylglycerol lipase
2-AG	2-Arachidonoylglycerol
A2A	Adenosine A2A receptor
PPAR-γ	Peroxisome Proliferator-Activated Receptor Gamma
PGC-1α	Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
KOR	κ-opioid receptor
MOR	μ-opioid receptor
NMDA	N-Methyl-D-Aspartate receptor
TLR-4	Toll-like receptor-4
CCl4-	Carbon tetrachloride
SEDDS	Self-emulsifying drug delivery system
ERK	Extracellular signal-regulated kinase
JNK	c-Jun N-terminal kinase
TGF-β1	Transforming Growth Factor Beta 1
GAP-43	Growth-Associated Protein 43
NGF	Nerve Growth Factor
PGE2	Prostaglandin E2
MK-801	Dizocilpine maleate
NO–cGMP	Nitric Oxide–cyclic Guanosine Monophosphate pathway
GRAS	Generally Recognized As Safe
FDA	Food and Drug Administration